Schizophrenia.com
Aripiprazole or metformin for hyperprolactinemia in women with schizophrenia: A 6-month, real-world chart review study
News
everhopeful
April 21, 2025, 12:22pm
1
Related topics
Topic
Replies
Views
Activity
Efficacy and Safety of Adjunctive Aripiprazole, Metformin, and Paeoniae-Glycyrrhiza Decoction for Antipsychotic-Induced Hyperprolactinemia
News
0
234
October 18, 2021
Evaluating the efficacy of metformin in reducing hyperprolactinemia among patients with schizophrenia: A meta-analysis of randomized controlled trials
News
0
37
March 25, 2025
Lowering Prolactin Levels in Patients With Psychosis
News
1
221
July 10, 2020
Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis: Results From the DAAMSEL Clinical Trial
News
4
1003
July 13, 2018
Effects of aripiprazole on prolactin levels and differences in effectiveness in patients with schizophrenia: a post-hoc analysis of the real-world data of a multicenter study
News
1
49
September 14, 2024